<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dcterms="http://purl.org/dc/terms/"
         xmlns:bibo="http://purl.org/ontology/bibo/"
         xmlns:foaf="http://xmlns.com/foaf/0.1/"
         xmlns:ad="http://schemas.talis.com/2005/address/schema-20060627"
         xmlns:projectfunding="http://vocab.ox.ac.uk/projectfunding"
         xmlns:madec="http://castor.example.fr/-/schema"
         xmlns:nctp="http://bibliotep.example.fr/-/schema"
>
  <rdf:Description rdf:about="test">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Instance" />
  </rdf:Description>
  <rdf:Description rdf:about="069685">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Notice" />
    <dcterms:isPartOf rdf:resource="test" />
    <nctp:organismsTG>Animals</nctp:organismsTG>
    <nctp:organismsTG>Chordata</nctp:organismsTG>
    <nctp:organismsTG>Eukaryota</nctp:organismsTG>
    <nctp:organismsTG>Mammals</nctp:organismsTG>
    <nctp:organismsTG>Muridae</nctp:organismsTG>
    <nctp:organismsTG>Murinae</nctp:organismsTG>
    <nctp:organismsTG>Rodentia</nctp:organismsTG>
    <nctp:organismsTG>Vertebrates</nctp:organismsTG>
    <nctp:organismsTS>Animals</nctp:organismsTS>
    <nctp:organismsTS>Rats</nctp:organismsTS>
    <nctp:organismsMeSH>Animals</nctp:organismsMeSH>
    <nctp:organismsMeSH>Rats</nctp:organismsMeSH>
    <nctp:anatomyTG>Central Nervous System</nctp:anatomyTG>
    <nctp:anatomyTG>Nervous System</nctp:anatomyTG>
    <nctp:anatomySH>Brain [Metabolism]</nctp:anatomySH>
    <nctp:anatomySH>Brain [Radionuclide imaging]</nctp:anatomySH>
    <nctp:anatomy>Brain</nctp:anatomy>
    <nctp:physiologyTG>Chemical Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Pharmacological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Physiological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTS>Structure-Activity Relationship</nctp:physiologyTS>
    <nctp:physiology>Structure-Activity Relationship</nctp:physiology>
    <nctp:biochemicalsChemicalsTG>Azoles</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds, 1-Ring</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Indicators and Reagents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Inorganic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Iodine Isotopes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Isotopes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Laboratory Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Organic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Radioisotopes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfur Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsSH>Radiopharmaceuticals [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Radiopharmaceuticals [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Radiopharmaceuticals [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsTS>3-((2-fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>3-((2-fluorothiazol-4-yl)ethynyl)benzonitrile</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>3-((2-iodothiazol)-4-ethynyl)-5-fluorobenzonitrile</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Fluorine Radioisotopes</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Iodine Radioisotopes</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Radiopharmaceuticals</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Thiazoles</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicals>3-((2-fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>3-((2-fluorothiazol-4-yl)ethynyl)benzonitrile</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>3-((2-iodothiazol)-4-ethynyl)-5-fluorobenzonitrile</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Fluorine Radioisotopes</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Iodine Radioisotopes</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Radiopharmaceuticals</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Thiazoles</nctp:biochemicalsChemicals>
    <nctp:technicalsTG>Diagnosis</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques and Procedures</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques, Radioisotope</nctp:technicalsTG>
    <nctp:technicalsTG>Image Enhancement</nctp:technicalsTG>
    <nctp:technicalsTG>Image Interpretation, Computer-Assisted</nctp:technicalsTG>
    <nctp:technicalsTG>Photography</nctp:technicalsTG>
    <nctp:technicalsTG>Radionuclide Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography, Emission-Computed</nctp:technicalsTG>
    <nctp:technicalsTS>Positron-Emission Tomography</nctp:technicalsTS>
    <nctp:technicalsTS>Tomography, Emission-Computed, Single-Photon</nctp:technicalsTS>
    <nctp:technicals>Positron-Emission Tomography</nctp:technicals>
    <nctp:technicals>Tomography, Emission-Computed, Single-Photon</nctp:technicals>
    <nctp:proteinsTG>Membrane Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Amino Acid</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Cell Surface</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, G-Protein-Coupled</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Glutamate</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Metabotropic Glutamate</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Neurotransmitter</nctp:proteinsTG>
    <nctp:proteinsSH>Receptors, Metabotropic Glutamate [Metabolism]</nctp:proteinsSH>
    <nctp:proteinsTS>Receptors, Metabotropic Glutamate</nctp:proteinsTS>
    <nctp:proteinsTS>metabotropic glutamate receptor 5</nctp:proteinsTS>
    <nctp:proteins>Receptors, Metabotropic Glutamate</nctp:proteins>
    <nctp:proteins>metabotropic glutamate receptor 5</nctp:proteins>
    <nctp:organisms>Animal</nctp:organisms>
    <nctp:organisms>Rat</nctp:organisms>
    <nctp:medicalSpeciality>Neurology</nctp:medicalSpeciality>
    <nctp:anatomicalSystems>Nervous System</nctp:anatomicalSystems>
    <nctp:imagingTechniques>PET</nctp:imagingTechniques>
    <nctp:imagingTechniques>SPECT</nctp:imagingTechniques>
    <nctp:element>Fluorine Radioisotopes</nctp:element>
    <nctp:element>Iodine Radioisotopes</nctp:element>
    <nctp:element>Others</nctp:element>
    <nctp:isotope>Fluorine 18</nctp:isotope>
    <nctp:isotope>Iodine 123</nctp:isotope>
    <bibo:pmid>21207959</bibo:pmid>
    <projectfunding:grant>research support, n.i.h., extramural</projectfunding:grant>
    <projectfunding:grant>research support, n.i.h., intramural</projectfunding:grant>
    <dcterms:type>journal article</dcterms:type>
    <nctp:freeAccess>21207959@@Full Text available</nctp:freeAccess>
    <dcterms:source>J Med Chem. 2011 Feb 10;54(3):901-8.</dcterms:source>
    <dcterms:language>eng</dcterms:language>
    <madec:medlineSubHeading>Chemical Synthesis</madec:medlineSubHeading>
    <madec:medlineSubHeading>Chemistry</madec:medlineSubHeading>
    <madec:medlineSubHeading>Metabolism</madec:medlineSubHeading>
    <madec:medlineSubHeading>Pharmacokinetics</madec:medlineSubHeading>
    <madec:medlineSubHeading>Radionuclide Imaging</madec:medlineSubHeading>
    <dcterms:creator>Sim&#233;on FG</dcterms:creator>
    <dcterms:creator>Wendahl MT</dcterms:creator>
    <dcterms:creator>Pike VW</dcterms:creator>
    <dcterms:issued>20120808</dcterms:issued>
    <madec:medlineIndexationDate>2012-10-17</madec:medlineIndexationDate>
    <madec:pubmedEntryDate>2011-01-7</madec:pubmedEntryDate>
    <dcterms:created>2011-01-7</dcterms:created>
    <madec:publicationYear>2011</madec:publicationYear>
    <bibo:Journal>Journal of medicinal chemistry</bibo:Journal>
    <dcterms:title>Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.</dcterms:title>
    <dcterms:abstract>The structure of the potent selective mGlu(5) ligand, SP203 (1, 3-fluoro-5-[[2-(fluoromethyl)thiazol-4-yl]ethynyl]benzonitrile), was modified by replacing the 2-fluoromethyl substituent with an amino or halo substituent and by variation of substituents in the distal aromatic ring to provide a series of new high-affinity mGlu(5) ligands. In this series, among the most potent ligands obtained, the 2-chloro-thiazoles 7a and 7b and the 2-fluorothiazole 10b showed subnanomolar mGlu(5) affinity. 10b also displayed &#62;10000-fold selectivity over all other metabotropic receptor subtypes plus a wide range of other receptors and binding sites. The 2-fluorothiazoles 10a and 10b were labeled using [(18)F]fluoride ion (t(1/2) = 109.7 min) in moderately high radiochemical yield to provide potential radioligands that may resist troublesome radiodefluorination during the imaging of brain mGlu(5) with position emission tomography. The iodo compound 9b has nanomolar affinity for mGlu(5) and may also serve as a lead to a potential (123)I-labeled ligand for imaging brain mGlu(5) with single photon emission computed tomography.</dcterms:abstract>
    <madec:affiliation rdf:resource="aff-069685-1" />
    <madec:publicationCountry>United States</madec:publicationCountry>
    <bibo:issn>0022-2623</bibo:issn>
  </rdf:Description>
  <rdf:Description rdf:about="aff-069685-1">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Affiliation" />
    <madec:totalAffiliation>Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Building 10, Room B3C346A, 10 Center Drive, Bethesda, MD 20892-1003, USA. simeonf@mail.nih.gov</madec:totalAffiliation>
    <ad:countryName>USA</ad:countryName>
  </rdf:Description>
  <rdf:Description rdf:about="069686">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Notice" />
    <dcterms:isPartOf rdf:resource="test" />
    <nctp:organismsTG>Animals</nctp:organismsTG>
    <nctp:organismsTG>Catarrhini</nctp:organismsTG>
    <nctp:organismsTG>Chordata</nctp:organismsTG>
    <nctp:organismsTG>Cricetinae</nctp:organismsTG>
    <nctp:organismsTG>Eukaryota</nctp:organismsTG>
    <nctp:organismsTG>Haplorhini</nctp:organismsTG>
    <nctp:organismsTG>Hominidae</nctp:organismsTG>
    <nctp:organismsTG>Mammals</nctp:organismsTG>
    <nctp:organismsTG>Muridae</nctp:organismsTG>
    <nctp:organismsTG>Murinae</nctp:organismsTG>
    <nctp:organismsTG>Primates</nctp:organismsTG>
    <nctp:organismsTG>Rats</nctp:organismsTG>
    <nctp:organismsTG>Rodentia</nctp:organismsTG>
    <nctp:organismsTG>Vertebrates</nctp:organismsTG>
    <nctp:organismsTS>Animals</nctp:organismsTS>
    <nctp:organismsTS>Cricetinae</nctp:organismsTS>
    <nctp:organismsTS>Cricetulus</nctp:organismsTS>
    <nctp:organismsTS>Humans</nctp:organismsTS>
    <nctp:organismsTS>Male</nctp:organismsTS>
    <nctp:organismsTS>Mice</nctp:organismsTS>
    <nctp:organismsTS>Rats</nctp:organismsTS>
    <nctp:organismsTS>Rats, Sprague-Dawley</nctp:organismsTS>
    <nctp:organismsMeSH>Animals</nctp:organismsMeSH>
    <nctp:organismsMeSH>Cricetinae</nctp:organismsMeSH>
    <nctp:organismsMeSH>Cricetulus</nctp:organismsMeSH>
    <nctp:organismsMeSH>Humans</nctp:organismsMeSH>
    <nctp:organismsMeSH>Male</nctp:organismsMeSH>
    <nctp:organismsMeSH>Mice</nctp:organismsMeSH>
    <nctp:organismsMeSH>Rats</nctp:organismsMeSH>
    <nctp:organismsMeSH>Rats, Sprague-Dawley</nctp:organismsMeSH>
    <nctp:anatomyTG>Cell Line</nctp:anatomyTG>
    <nctp:anatomyTG>Cell Line, Tumor</nctp:anatomyTG>
    <nctp:anatomyTG>Cells</nctp:anatomyTG>
    <nctp:anatomyTG>Cells, Cultured</nctp:anatomyTG>
    <nctp:anatomyTG>Epithelial Cells</nctp:anatomyTG>
    <nctp:anatomyTG>Tumor Cells, Cultured</nctp:anatomyTG>
    <nctp:anatomyTS>CHO Cells</nctp:anatomyTS>
    <nctp:anatomyTS>Caco-2 Cells</nctp:anatomyTS>
    <nctp:anatomy>CHO Cells</nctp:anatomy>
    <nctp:anatomy>Caco-2 Cells</nctp:anatomy>
    <nctp:physiologyTG>Biological Transport</nctp:physiologyTG>
    <nctp:physiologyTG>Cell Physiological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Chemical Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Metabolic Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Metabolism</nctp:physiologyTG>
    <nctp:physiologyTG>Pharmacological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Physiological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTS>Cell Membrane Permeability</nctp:physiologyTS>
    <nctp:physiologyTS>Structure-Activity Relationship</nctp:physiologyTS>
    <nctp:physiology>Cell Membrane Permeability</nctp:physiology>
    <nctp:physiology>Structure-Activity Relationship</nctp:physiology>
    <nctp:biochemicalsChemicalsTG>Anti-Dyskinesia Agents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Azoles</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Central Nervous System Agents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds, 1-Ring</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Hydroxides</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Inorganic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Molecular Mechanisms of Pharmacological Action</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Neurotransmitter Agents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Organic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Organophosphorus Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Oxides</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Oxygen Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Phosphoric Acid Esters</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Purinergic Agents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Purinergic Antagonists</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Purinergic P1 Receptor Antagonists</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfur Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Thiazoles</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsSH>Adenosine A2 Receptor Antagonists [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Adenosine A2 Receptor Antagonists [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Adenosine A2 Receptor Antagonists [Pharmacology]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Antiparkinson Agents [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Antiparkinson Agents [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Antiparkinson Agents [Pharmacology]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Phosphoric Acid Esters [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Phosphoric Acid Esters [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Phosphoric Acid Esters [Pharmacology]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Pharmacokinetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Thiazoles [Pharmacology]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsTS>Adenosine A2 Receptor Antagonists</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Antiparkinson Agents</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Phosphoric Acid Esters</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Thiazoles</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Water</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>phosphoric acid mono-(2-(4-(3,3-dimethylbutyrylamino)-3,5-difluorobenzoylimino)thiazol-3-ylmethyl) ester</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicals>Adenosine A2 Receptor Antagonists</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Antiparkinson Agents</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Phosphoric Acid Esters</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Thiazoles</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Water</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>phosphoric acid mono-(2-(4-(3,3-dimethylbutyrylamino)-3,5-difluorobenzoylimino)thiazol-3-ylmethyl) ester</nctp:biochemicalsChemicals>
    <nctp:technicalsTG>Chemistry Techniques, Analytical</nctp:technicalsTG>
    <nctp:technicalsTG>Clinical Laboratory Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Crystallography</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnosis</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques and Procedures</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques, Endocrine</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques, Radioisotope</nctp:technicalsTG>
    <nctp:technicalsTG>Investigative Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Models, Theoretical</nctp:technicalsTG>
    <nctp:technicalsTG>Pharmaceutical Preparations</nctp:technicalsTG>
    <nctp:technicalsTG>Technology, Pharmaceutical</nctp:technicalsTG>
    <nctp:technicalsTG>X-Ray Diffraction</nctp:technicalsTG>
    <nctp:technicalsSH>Prodrugs [Chemical synthesis]</nctp:technicalsSH>
    <nctp:technicalsSH>Prodrugs [Pharmacokinetics]</nctp:technicalsSH>
    <nctp:technicalsSH>Prodrugs [Pharmacology]</nctp:technicalsSH>
    <nctp:technicalsTS>Crystallography, X-Ray</nctp:technicalsTS>
    <nctp:technicalsTS>High-Throughput Screening Assays</nctp:technicalsTS>
    <nctp:technicalsTS>Models, Molecular</nctp:technicalsTS>
    <nctp:technicalsTS>Prodrugs</nctp:technicalsTS>
    <nctp:technicalsTS>Radioligand Assay</nctp:technicalsTS>
    <nctp:technicals>Crystallography, X-Ray</nctp:technicals>
    <nctp:technicals>High-Throughput Screening Assays</nctp:technicals>
    <nctp:technicals>Models, Molecular</nctp:technicals>
    <nctp:technicals>Prodrugs</nctp:technicals>
    <nctp:technicals>Radioligand Assay</nctp:technicals>
    <nctp:miscellaneousTG>Chemical Phenomena</nctp:miscellaneousTG>
    <nctp:miscellaneousTG>Isomerism</nctp:miscellaneousTG>
    <nctp:miscellaneousTG>Organic Chemistry Phenomena</nctp:miscellaneousTG>
    <nctp:miscellaneousTG>Physicochemical Phenomena</nctp:miscellaneousTG>
    <nctp:miscellaneousTS>Solubility</nctp:miscellaneousTS>
    <nctp:miscellaneousTS>Stereoisomerism</nctp:miscellaneousTS>
    <nctp:miscellaneous>Solubility</nctp:miscellaneous>
    <nctp:miscellaneous>Stereoisomerism</nctp:miscellaneous>
    <nctp:organisms>Animal</nctp:organisms>
    <nctp:organisms>Hamster</nctp:organisms>
    <nctp:organisms>Mice</nctp:organisms>
    <nctp:organisms>Rat</nctp:organisms>
    <nctp:medicalSpeciality>Neurology</nctp:medicalSpeciality>
    <nctp:imagingTechniques>Radioligand Assay</nctp:imagingTechniques>
    <madec:CASNumber>madec:CASNumber 7732-18-5 Water</madec:CASNumber>
    <bibo:pmid>21210664</bibo:pmid>
    <dcterms:type>journal article</dcterms:type>
    <dcterms:source>J Med Chem. 2011 Feb 10;54(3):751-64.</dcterms:source>
    <dcterms:language>eng</dcterms:language>
    <madec:medlineSubHeading>Chemical Synthesis</madec:medlineSubHeading>
    <madec:medlineSubHeading>Pharmacokinetics</madec:medlineSubHeading>
    <madec:medlineSubHeading>Pharmacology</madec:medlineSubHeading>
    <dcterms:creator>Sams AG</dcterms:creator>
    <dcterms:creator>Mikkelsen GK</dcterms:creator>
    <dcterms:creator>Larsen M</dcterms:creator>
    <dcterms:creator>Langg&#229;rd M</dcterms:creator>
    <dcterms:creator>Howells ME</dcterms:creator>
    <dcterms:creator>Schr&#248;der TJ</dcterms:creator>
    <dcterms:creator>Brennum LT</dcterms:creator>
    <dcterms:creator>Torup L</dcterms:creator>
    <dcterms:creator>J&#248;rgensen EB</dcterms:creator>
    <dcterms:creator>Bundgaard C</dcterms:creator>
    <dcterms:creator>Kreilg&#229;rd M</dcterms:creator>
    <dcterms:creator>Bang-Andersen B</dcterms:creator>
    <dcterms:issued>20120808</dcterms:issued>
    <madec:medlineIndexationDate>2012-10-17</madec:medlineIndexationDate>
    <madec:pubmedEntryDate>2011-01-8</madec:pubmedEntryDate>
    <dcterms:created>2011-01-8</dcterms:created>
    <madec:publicationYear>2011</madec:publicationYear>
    <bibo:Journal>Journal of medicinal chemistry</bibo:Journal>
    <dcterms:title>Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.</dcterms:title>
    <dcterms:abstract>The discovery and structure-activity relationship of a series of hA(2A) receptor antagonists is described. Compound 28 was selected from the series as a potent and selective compound and was shown to be efficacious in an in vivo model of Parkinson's disease. It had acceptable ADME properties; however, the low intrinsic solubility of this compound was limiting for its developability, because the oral bioavailability from dosing in suspension was significantly lower than the oral bioavailability from solution dosage. As a consequence, prodrugs of 28 were prepared with dramatically increased aqueous solubility. The prodrugs efficiently delivered 28 into systemic circulation, with no detectable levels of prodrug in plasma samples. From this investigation, we selected 32 (Lu AA47070), a phosphonooxymethylene prodrug of 28, as a drug candidate.</dcterms:abstract>
    <madec:affiliation rdf:resource="aff-069686-1" />
    <madec:publicationCountry>United States</madec:publicationCountry>
    <bibo:issn>0022-2623</bibo:issn>
  </rdf:Description>
  <rdf:Description rdf:about="aff-069686-1">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Affiliation" />
    <madec:totalAffiliation>Medicinal Chemistry Research, Lundbeck Research. anette.sams@leo-pharma.com</madec:totalAffiliation>
  </rdf:Description>
  <rdf:Description rdf:about="069691">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Notice" />
    <dcterms:isPartOf rdf:resource="test" />
    <nctp:organismsTG>Animals</nctp:organismsTG>
    <nctp:organismsTG>Catarrhini</nctp:organismsTG>
    <nctp:organismsTG>Chordata</nctp:organismsTG>
    <nctp:organismsTG>Eukaryota</nctp:organismsTG>
    <nctp:organismsTG>Haplorhini</nctp:organismsTG>
    <nctp:organismsTG>Hominidae</nctp:organismsTG>
    <nctp:organismsTG>Mammals</nctp:organismsTG>
    <nctp:organismsTG>Primates</nctp:organismsTG>
    <nctp:organismsTG>Vertebrates</nctp:organismsTG>
    <nctp:organismsTS>Female</nctp:organismsTS>
    <nctp:organismsTS>Humans</nctp:organismsTS>
    <nctp:organismsTS>Male</nctp:organismsTS>
    <nctp:organismsMeSH>Female</nctp:organismsMeSH>
    <nctp:organismsMeSH>Humans</nctp:organismsMeSH>
    <nctp:organismsMeSH>Male</nctp:organismsMeSH>
    <nctp:biochemicalsChemicalsTG>Antimetabolites</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Antimetabolites, Antineoplastic</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Carbohydrates</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Coenzymes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Deoxy Sugars</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Deoxyglucose</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Folic Acid</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Formyltetrahydrofolates</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds, 1-Ring</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Heterocyclic Compounds, 2-Ring</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Immunosuppressive Agents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Indicators and Reagents</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Laboratory Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Pteridines</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Pterins</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Pyrimidines</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Pyrimidinones</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Radiopharmaceuticals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Tetrahydrofolates</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Uracil</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Vitamin B Complex</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsSH>Fluorodeoxyglucose F18 [Diagnostic use]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Fluorouracil [Administration &#38; dosage]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Leucovorin [Administration &#38; dosage]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Radiopharmaceuticals [Diagnostic use]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsTS>Fluorodeoxyglucose F18</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Fluorouracil</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Leucovorin</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Radiopharmaceuticals</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicals>Fluorodeoxyglucose F18</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Fluorouracil</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Leucovorin</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Radiopharmaceuticals</nctp:biochemicalsChemicals>
    <nctp:technicalsTG>Antineoplastic Protocols</nctp:technicalsTG>
    <nctp:technicalsTG>Clinical Protocols</nctp:technicalsTG>
    <nctp:technicalsTG>Cohort Studies</nctp:technicalsTG>
    <nctp:technicalsTG>Combined Modality Therapy</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnosis</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques and Procedures</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques, Radioisotope</nctp:technicalsTG>
    <nctp:technicalsTG>Drug Therapy</nctp:technicalsTG>
    <nctp:technicalsTG>Drug Therapy, Combination</nctp:technicalsTG>
    <nctp:technicalsTG>Epidemiologic Methods</nctp:technicalsTG>
    <nctp:technicalsTG>Epidemiologic Research Design</nctp:technicalsTG>
    <nctp:technicalsTG>Epidemiologic Studies</nctp:technicalsTG>
    <nctp:technicalsTG>Epidemiologic Study Characteristics as Topic</nctp:technicalsTG>
    <nctp:technicalsTG>Health Care Evaluation Mechanisms</nctp:technicalsTG>
    <nctp:technicalsTG>Health Care Facilities, Manpower, and Services</nctp:technicalsTG>
    <nctp:technicalsTG>Health Care Quality, Access, and Evaluation</nctp:technicalsTG>
    <nctp:technicalsTG>Health Services</nctp:technicalsTG>
    <nctp:technicalsTG>Image Enhancement</nctp:technicalsTG>
    <nctp:technicalsTG>Image Interpretation, Computer-Assisted</nctp:technicalsTG>
    <nctp:technicalsTG>Investigative Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Longitudinal Studies</nctp:technicalsTG>
    <nctp:technicalsTG>Patient Care</nctp:technicalsTG>
    <nctp:technicalsTG>Perioperative Care</nctp:technicalsTG>
    <nctp:technicalsTG>Photography</nctp:technicalsTG>
    <nctp:technicalsTG>Positron-Emission Tomography</nctp:technicalsTG>
    <nctp:technicalsTG>Prognosis</nctp:technicalsTG>
    <nctp:technicalsTG>Public Health</nctp:technicalsTG>
    <nctp:technicalsTG>Quality of Health Care</nctp:technicalsTG>
    <nctp:technicalsTG>Radiographic Image Enhancement</nctp:technicalsTG>
    <nctp:technicalsTG>Radiography</nctp:technicalsTG>
    <nctp:technicalsTG>Radionuclide Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Radiotherapy</nctp:technicalsTG>
    <nctp:technicalsTG>Sensitivity and Specificity</nctp:technicalsTG>
    <nctp:technicalsTG>Statistics as Topic</nctp:technicalsTG>
    <nctp:technicalsTG>Surgical Procedures, Operative</nctp:technicalsTG>
    <nctp:technicalsTG>Therapeutics</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography, Emission-Computed</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography, X-Ray</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography, X-Ray Computed</nctp:technicalsTG>
    <nctp:technicalsSH>Antineoplastic Combined Chemotherapy Protocols [Therapeutic use]</nctp:technicalsSH>
    <nctp:technicalsTS>Chemoradiotherapy</nctp:technicalsTS>
    <nctp:technicalsTS>Neoadjuvant Therapy</nctp:technicalsTS>
    <nctp:technicalsTS>Neoplasm Staging</nctp:technicalsTS>
    <nctp:technicalsTS>Positron-Emission Tomography and Computed Tomography</nctp:technicalsTS>
    <nctp:technicalsTS>Preoperative Care</nctp:technicalsTS>
    <nctp:technicalsTS>Prognosis</nctp:technicalsTS>
    <nctp:technicalsTS>Prospective Studies</nctp:technicalsTS>
    <nctp:technicalsTS>ROC Curve</nctp:technicalsTS>
    <nctp:technicals>Antineoplastic Combined Chemotherapy Protocols</nctp:technicals>
    <nctp:technicals>Chemoradiotherapy</nctp:technicals>
    <nctp:technicals>Neoadjuvant Therapy</nctp:technicals>
    <nctp:technicals>Neoplasm Staging</nctp:technicals>
    <nctp:technicals>Positron-Emission Tomography and Computed Tomography</nctp:technicals>
    <nctp:technicals>Preoperative Care</nctp:technicals>
    <nctp:technicals>Prognosis</nctp:technicals>
    <nctp:technicals>Prospective Studies</nctp:technicals>
    <nctp:technicals>ROC Curve</nctp:technicals>
    <nctp:miscellaneousTG>Adult</nctp:miscellaneousTG>
    <nctp:miscellaneousTG>Age Groups</nctp:miscellaneousTG>
    <nctp:miscellaneousTG>Persons</nctp:miscellaneousTG>
    <nctp:miscellaneousTS>Adult</nctp:miscellaneousTS>
    <nctp:miscellaneousTS>Aged</nctp:miscellaneousTS>
    <nctp:miscellaneousTS>Middle Aged</nctp:miscellaneousTS>
    <nctp:miscellaneous>Adult</nctp:miscellaneous>
    <nctp:miscellaneous>Aged</nctp:miscellaneous>
    <nctp:miscellaneous>Middle Aged</nctp:miscellaneous>
    <nctp:neoplasmsTG>Carcinoma</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Colorectal Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Digestive System Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Digestive System Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Gastrointestinal Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Gastrointestinal Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Intestinal Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Intestinal Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms by Histologic Type</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms by Site</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms, Glandular and Epithelial</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Rectal Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsSH>Adenocarcinoma [Pathology]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Adenocarcinoma [Radionuclide imaging]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Adenocarcinoma [Therapy]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Rectal Neoplasms [Pathology]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Rectal Neoplasms [Radionuclide imaging]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Rectal Neoplasms [Therapy]</nctp:neoplasmsSH>
    <nctp:neoplasmsMeSH>Adenocarcinoma</nctp:neoplasmsMeSH>
    <nctp:neoplasmsMeSH>Rectal Neoplasms</nctp:neoplasmsMeSH>
    <nctp:medicalSpeciality>Oncology</nctp:medicalSpeciality>
    <nctp:neoplasms>Digestive System Neoplasms</nctp:neoplasms>
    <nctp:neoplasms>Neoplasms, Glandular and Epithelial</nctp:neoplasms>
    <nctp:imagingTechniques>PET</nctp:imagingTechniques>
    <nctp:element>Fluorine Radioisotopes</nctp:element>
    <nctp:element>Others</nctp:element>
    <nctp:isotope>Fluorine 18</nctp:isotope>
    <madec:CASNumber>madec:CASNumber 51-21-8 Fluorouracil</madec:CASNumber>
    <madec:CASNumber>madec:CASNumber 58-05-9 Leucovorin</madec:CASNumber>
    <madec:CASNumber>madec:CASNumber 63503-12-8 Fluorodeoxyglucose F18</madec:CASNumber>
    <bibo:pmid>21422901</bibo:pmid>
    <projectfunding:grant>research support, non-u.s. gov't</projectfunding:grant>
    <dcterms:type>journal article</dcterms:type>
    <dcterms:source>Am J Clin Oncol. 2012 Aug;35(4):340-4.</dcterms:source>
    <dcterms:language>eng</dcterms:language>
    <madec:medlineSubHeading>Administration &#38; Dosage</madec:medlineSubHeading>
    <madec:medlineSubHeading>Diagnostic Use</madec:medlineSubHeading>
    <madec:medlineSubHeading>Pathology</madec:medlineSubHeading>
    <madec:medlineSubHeading>Radionuclide Imaging</madec:medlineSubHeading>
    <madec:medlineSubHeading>Therapeutic Use</madec:medlineSubHeading>
    <madec:medlineSubHeading>Therapy</madec:medlineSubHeading>
    <dcterms:creator>Huh JW</dcterms:creator>
    <dcterms:creator>Min JJ</dcterms:creator>
    <dcterms:creator>Lee JH</dcterms:creator>
    <dcterms:creator>Kim HR</dcterms:creator>
    <dcterms:creator>Kim YJ</dcterms:creator>
    <dcterms:issued>20120719</dcterms:issued>
    <madec:medlineIndexationDate>2012-10-10</madec:medlineIndexationDate>
    <madec:pubmedEntryDate>2011-03-23</madec:pubmedEntryDate>
    <dcterms:created>2011-03-23</dcterms:created>
    <madec:publicationYear>2012</madec:publicationYear>
    <bibo:Journal>American journal of clinical oncology</bibo:Journal>
    <dcterms:title>The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.</dcterms:title>
    <dcterms:abstract>PURPOSE : This study prospectively assessed the value of sequential fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scans for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiation.METHODS : Fifty consecutive patients with locally advanced rectal cancer were enrolled. The treatment consisted of concurrent chemoradiation, which included preoperative 5-fluorouracil-based chemotherapy and pelvic radiation (4500 to 5040 cGy); this was followed 8 weeks later (median: 55 d) by surgery with a curative intent. All the patients underwent FDG-PET/CT before and 5 weeks later (median: 35 d) after the completion of chemoradiation. We evaluated the measurements of the FDG uptake [maximum standardized uptake values (SUV(max))] and the percentage of SUV(max) difference [(response index (RI)] between the prechemoradiation and postchemoradiation FDG-PET/CT scans.RESULTS : After chemoradiation, 32 of 50 patients (64%) were classified as responders according to the tumor regression grade, which is based on the ratio of fibrosis to residual cancer (tumor regression grade 3-4). For all the patients, the mean prechemoradiation SUV(max) was 14.8, and this was significantly higher than the mean SUV(max) value of 6.1 at postchemoradiation (P&#60; 0.001). The mean RI was significantly higher in the responders than that in the nonresponder patients (62.6% vs. 31.2%, P = 0.001). The following parameters were obtained using a RI cutoff of 53.0% for defining a response to therapy: 75.0% sensitivity, 73.2% specificity, 82.8% positive predictive value, and 61.9% negative predictive value.CONCLUSIONS : The FDG-PET/CT parameters, and especially the RI, may be best for assessing the neoadjuvant chemoradiation response of locally advanced rectal cancer and these values can potentially assist physicians for planning the optimal treatment.</dcterms:abstract>
    <madec:affiliation rdf:resource="aff-069691-1" />
    <madec:publicationCountry>United States</madec:publicationCountry>
    <bibo:issn>0277-3732</bibo:issn>
  </rdf:Description>
  <rdf:Description rdf:about="aff-069691-1">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Affiliation" />
    <madec:totalAffiliation>Department of Surgery, Chonnam National University Hwasun Hospital, Gwangju, Korea.</madec:totalAffiliation>
    <ad:countryName>South Korea</ad:countryName>
  </rdf:Description>
  <rdf:Description rdf:about="069698">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Notice" />
    <dcterms:isPartOf rdf:resource="test" />
    <nctp:organismsTG>Animals</nctp:organismsTG>
    <nctp:organismsTG>Catarrhini</nctp:organismsTG>
    <nctp:organismsTG>Chordata</nctp:organismsTG>
    <nctp:organismsTG>Eukaryota</nctp:organismsTG>
    <nctp:organismsTG>Haplorhini</nctp:organismsTG>
    <nctp:organismsTG>Hominidae</nctp:organismsTG>
    <nctp:organismsTG>Mammals</nctp:organismsTG>
    <nctp:organismsTG>Muridae</nctp:organismsTG>
    <nctp:organismsTG>Murinae</nctp:organismsTG>
    <nctp:organismsTG>Primates</nctp:organismsTG>
    <nctp:organismsTG>Rodentia</nctp:organismsTG>
    <nctp:organismsTG>Vertebrates</nctp:organismsTG>
    <nctp:organismsTS>Animals</nctp:organismsTS>
    <nctp:organismsTS>Humans</nctp:organismsTS>
    <nctp:organismsTS>Mice</nctp:organismsTS>
    <nctp:organismsMeSH>Animals</nctp:organismsMeSH>
    <nctp:organismsMeSH>Humans</nctp:organismsMeSH>
    <nctp:organismsMeSH>Mice</nctp:organismsMeSH>
    <nctp:physiologyTG>Metabolic Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Pharmacokinetics</nctp:physiologyTG>
    <nctp:physiologyTG>Pharmacological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTG>Physiological Phenomena</nctp:physiologyTG>
    <nctp:physiologyTS>Tissue Distribution</nctp:physiologyTS>
    <nctp:physiology>Tissue Distribution</nctp:physiology>
    <nctp:biochemicalsChemicalsTG>Amino Acids</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Amino Acids, Neutral</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Amino Acids, Sulfur</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Elements</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Elements, Radioactive</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Inorganic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Metals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Metals, Heavy</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Molecular Mechanisms of Pharmacological Action</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Organic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfhydryl Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfur Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Transition Elements</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsSH>Amino Acids [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Chelating Agents [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Cysteine [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Peptides [Chemical synthesis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Peptides [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Technetium [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsTS>Amino Acids</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Chelating Agents</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Cysteine</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Peptides</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Technetium</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicals>Amino Acids</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Chelating Agents</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Cysteine</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Peptides</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Technetium</nctp:biochemicalsChemicals>
    <nctp:technicalsTG>Diagnosis</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques and Procedures</nctp:technicalsTG>
    <nctp:technicalsTG>Investigative Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Molecular Probe Techniques</nctp:technicalsTG>
    <nctp:technicalsTS>Isotope Labeling</nctp:technicalsTS>
    <nctp:technicalsTS>Molecular Imaging</nctp:technicalsTS>
    <nctp:technicals>Isotope Labeling</nctp:technicals>
    <nctp:technicals>Molecular Imaging</nctp:technicals>
    <nctp:proteinsTG>Biological Factors</nctp:proteinsTG>
    <nctp:proteinsTG>Biological Markers</nctp:proteinsTG>
    <nctp:proteinsTG>Enzymes</nctp:proteinsTG>
    <nctp:proteinsTG>Membrane Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Neoplasm Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Oncogene Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Phosphotransferases</nctp:proteinsTG>
    <nctp:proteinsTG>Phosphotransferases (Alcohol Group Acceptor)</nctp:proteinsTG>
    <nctp:proteinsTG>Protein Kinases</nctp:proteinsTG>
    <nctp:proteinsTG>Protein-Tyrosine Kinases</nctp:proteinsTG>
    <nctp:proteinsTG>Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Proto-Oncogene Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Receptor Protein-Tyrosine Kinases</nctp:proteinsTG>
    <nctp:proteinsTG>Receptor, erbB-2</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Cell Surface</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Growth Factor</nctp:proteinsTG>
    <nctp:proteinsTG>Receptors, Peptide</nctp:proteinsTG>
    <nctp:proteinsTG>Recombinant Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Transferases</nctp:proteinsTG>
    <nctp:proteinsTG>Tumor Markers, Biological</nctp:proteinsTG>
    <nctp:proteinsSH>Receptor, erbB-2 [Chemistry]</nctp:proteinsSH>
    <nctp:proteinsSH>Recombinant Fusion Proteins [Chemistry]</nctp:proteinsSH>
    <nctp:proteinsTS>ERBB2 protein, human</nctp:proteinsTS>
    <nctp:proteinsTS>Receptor, erbB-2</nctp:proteinsTS>
    <nctp:proteinsTS>Recombinant Fusion Proteins</nctp:proteinsTS>
    <nctp:proteins>ERBB2 protein, human</nctp:proteins>
    <nctp:proteins>Receptor, erbB-2</nctp:proteins>
    <nctp:proteins>Recombinant Fusion Proteins</nctp:proteins>
    <nctp:organisms>Animal</nctp:organisms>
    <nctp:organisms>Mice</nctp:organisms>
    <nctp:medicalSpeciality>Others</nctp:medicalSpeciality>
    <nctp:element>Technetium</nctp:element>
    <nctp:isotope>Technetium 99m</nctp:isotope>
    <madec:CASNumber>madec:CASNumber 52-90-4 Cysteine</madec:CASNumber>
    <madec:CASNumber>madec:CASNumber 7440-26-8 Technetium</madec:CASNumber>
    <madec:ECNumber>madec:ECNumber 2.7.10.1 ERBB2 protein, human</madec:ECNumber>
    <madec:ECNumber>madec:ECNumber 2.7.10.1 Receptor, erbB-2</madec:ECNumber>
    <bibo:pmid>21573874</bibo:pmid>
    <projectfunding:grant>research support, non-u.s. gov't</projectfunding:grant>
    <dcterms:type>journal article</dcterms:type>
    <dcterms:source>Amino Acids. 2012 May;42(5):1975-85.</dcterms:source>
    <dcterms:language>eng</dcterms:language>
    <madec:medlineSubHeading>Chemical Synthesis</madec:medlineSubHeading>
    <madec:medlineSubHeading>Chemistry</madec:medlineSubHeading>
    <dcterms:creator>Altai M</dcterms:creator>
    <dcterms:creator>W&#229;llberg H</dcterms:creator>
    <dcterms:creator>Orlova A</dcterms:creator>
    <dcterms:creator>Rosestedt M</dcterms:creator>
    <dcterms:creator>Hosseinimehr SJ</dcterms:creator>
    <dcterms:creator>Tolmachev V</dcterms:creator>
    <dcterms:creator>St&#229;hl S</dcterms:creator>
    <dcterms:issued>20120424</dcterms:issued>
    <madec:medlineIndexationDate>2012-10-02</madec:medlineIndexationDate>
    <madec:pubmedEntryDate>2011-05-17</madec:pubmedEntryDate>
    <dcterms:created>2011-05-17</dcterms:created>
    <madec:publicationYear>2012</madec:publicationYear>
    <bibo:Journal>Amino acids</bibo:Journal>
    <dcterms:title>Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules.</dcterms:title>
    <dcterms:abstract>Affibody molecules constitute a novel class of molecular display selected affinity proteins based on non-immunoglobulin scaffold. Preclinical investigations and pilot clinical data have demonstrated that Affibody molecules provide high contrast imaging of tumor-associated molecular targets shortly after injection. The use of cysteine-containing peptide-based chelators at the C-terminus of recombinant Affibody molecules enabled site-specific labeling with the radionuclide 99mTc. Earlier studies have demonstrated that position, composition and the order of amino acids in peptide-based chelators influence labeling stability, cellular processing and biodistribution of Affibody molecules. To investigate the influence of the amino acid order, a series of anti-HER2 Affibody molecules, containing GSGC, GEGC and GKGC chelators have been prepared and characterized. The affinity to HER2, cellular processing of 99mTc-labeled Affibody molecules and their biodistribution were investigated. These properties were compared with that of the previously studied 99mTc-labeled Affibody molecules containing GGSC, GGEC and GGKC chelators. All variants displayed picomolar affinities to HER2. The substitution of a single amino acid in the chelator had an appreciable influence on the cellular processing of 99mTc. The biodistribution of all 99mTc-labeled Affibody molecules was in general comparable, with the main difference in uptake and retention of radioactivity in excretory organs. The hepatic accumulation of radioactivity was higher for the lysine-containing chelators and the renal retention of 99mTc was significantly affected by the amino acid composition of chelators. The order of amino acids influenced renal uptake of some conjugates at 1 h after injection, but the difference decreased at later time points. Such information can be helpful for the development of other scaffold protein-based imaging and therapeutic radiolabeled conjugates.</dcterms:abstract>
    <madec:affiliation rdf:resource="aff-069698-1" />
    <madec:publicationCountry>Austria</madec:publicationCountry>
    <bibo:issn>0939-4451</bibo:issn>
  </rdf:Description>
  <rdf:Description rdf:about="aff-069698-1">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Affiliation" />
    <madec:totalAffiliation>Division of Biomedical Radiation Sciences, Department of Radiology, Oncology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, 75185, Uppsala, Sweden.</madec:totalAffiliation>
    <ad:countryName>Sweden</ad:countryName>
  </rdf:Description>
  <rdf:Description rdf:about="069699">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Notice" />
    <dcterms:isPartOf rdf:resource="test" />
    <nctp:organismsTG>Animals</nctp:organismsTG>
    <nctp:organismsTG>Catarrhini</nctp:organismsTG>
    <nctp:organismsTG>Chordata</nctp:organismsTG>
    <nctp:organismsTG>Eukaryota</nctp:organismsTG>
    <nctp:organismsTG>Haplorhini</nctp:organismsTG>
    <nctp:organismsTG>Hominidae</nctp:organismsTG>
    <nctp:organismsTG>Mammals</nctp:organismsTG>
    <nctp:organismsTG>Mice</nctp:organismsTG>
    <nctp:organismsTG>Mice, Mutant Strains</nctp:organismsTG>
    <nctp:organismsTG>Muridae</nctp:organismsTG>
    <nctp:organismsTG>Murinae</nctp:organismsTG>
    <nctp:organismsTG>Primates</nctp:organismsTG>
    <nctp:organismsTG>Rodentia</nctp:organismsTG>
    <nctp:organismsTG>Vertebrates</nctp:organismsTG>
    <nctp:organismsTS>Animals</nctp:organismsTS>
    <nctp:organismsTS>Female</nctp:organismsTS>
    <nctp:organismsTS>Humans</nctp:organismsTS>
    <nctp:organismsTS>Mice</nctp:organismsTS>
    <nctp:organismsTS>Mice, Nude</nctp:organismsTS>
    <nctp:organismsTS>Rats</nctp:organismsTS>
    <nctp:organismsMeSH>Animals</nctp:organismsMeSH>
    <nctp:organismsMeSH>Female</nctp:organismsMeSH>
    <nctp:organismsMeSH>Humans</nctp:organismsMeSH>
    <nctp:organismsMeSH>Mice</nctp:organismsMeSH>
    <nctp:organismsMeSH>Mice, Nude</nctp:organismsMeSH>
    <nctp:organismsMeSH>Rats</nctp:organismsMeSH>
    <nctp:anatomyTG>Cell Line</nctp:anatomyTG>
    <nctp:anatomyTG>Cells</nctp:anatomyTG>
    <nctp:anatomyTG>Cells, Cultured</nctp:anatomyTG>
    <nctp:anatomyTG>Tumor Cells, Cultured</nctp:anatomyTG>
    <nctp:anatomyTS>Cell Line, Tumor</nctp:anatomyTS>
    <nctp:anatomy>Cell Line, Tumor</nctp:anatomy>
    <nctp:biochemicalsChemicalsTG>Amino Acids</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Amino Acids, Neutral</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Amino Acids, Sulfur</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Biological Factors</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Biological Markers</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Inorganic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Isotopes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Organic Chemicals</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Radioisotopes</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfhydryl Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsTG>Sulfur Compounds</nctp:biochemicalsChemicalsTG>
    <nctp:biochemicalsChemicalsSH>Copper Radioisotopes [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Cysteine [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Cysteine [Genetics]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Cysteine [Metabolism]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Organometallic Compounds [Chemistry]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Tumor Markers, Biological [Analysis]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsSH>Tumor Markers, Biological [Metabolism]</nctp:biochemicalsChemicalsSH>
    <nctp:biochemicalsChemicalsTS>Copper Radioisotopes</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Cysteine</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Organometallic Compounds</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicalsTS>Tumor Markers, Biological</nctp:biochemicalsChemicalsTS>
    <nctp:biochemicalsChemicals>Copper Radioisotopes</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Cysteine</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Organometallic Compounds</nctp:biochemicalsChemicals>
    <nctp:biochemicalsChemicals>Tumor Markers, Biological</nctp:biochemicalsChemicals>
    <nctp:technicalsTG>Diagnosis</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques and Procedures</nctp:technicalsTG>
    <nctp:technicalsTG>Diagnostic Techniques, Radioisotope</nctp:technicalsTG>
    <nctp:technicalsTG>Genetic Engineering</nctp:technicalsTG>
    <nctp:technicalsTG>Genetic Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Image Enhancement</nctp:technicalsTG>
    <nctp:technicalsTG>Image Interpretation, Computer-Assisted</nctp:technicalsTG>
    <nctp:technicalsTG>Investigative Techniques</nctp:technicalsTG>
    <nctp:technicalsTG>Photography</nctp:technicalsTG>
    <nctp:technicalsTG>Radionuclide Imaging</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography</nctp:technicalsTG>
    <nctp:technicalsTG>Tomography, Emission-Computed</nctp:technicalsTG>
    <nctp:technicalsSH>Positron-Emission Tomography [Methods]</nctp:technicalsSH>
    <nctp:technicalsSH>Protein Engineering [Methods]</nctp:technicalsSH>
    <nctp:technicalsTS>Neoplasm Transplantation</nctp:technicalsTS>
    <nctp:technicals>Neoplasm Transplantation</nctp:technicals>
    <nctp:technicals>Positron-Emission Tomography</nctp:technicals>
    <nctp:technicals>Protein Engineering</nctp:technicals>
    <nctp:proteinsTG>Antibodies</nctp:proteinsTG>
    <nctp:proteinsTG>Antibodies, Monoclonal</nctp:proteinsTG>
    <nctp:proteinsTG>Antigens</nctp:proteinsTG>
    <nctp:proteinsTG>Antigens, CD</nctp:proteinsTG>
    <nctp:proteinsTG>Antigens, Differentiation</nctp:proteinsTG>
    <nctp:proteinsTG>Antigens, Surface</nctp:proteinsTG>
    <nctp:proteinsTG>Biological Factors</nctp:proteinsTG>
    <nctp:proteinsTG>Biological Markers</nctp:proteinsTG>
    <nctp:proteinsTG>Blood Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Cell Adhesion Molecules</nctp:proteinsTG>
    <nctp:proteinsTG>Cell Adhesion Molecules, Neuron-Glia</nctp:proteinsTG>
    <nctp:proteinsTG>Cell Adhesion Molecules, Neuronal</nctp:proteinsTG>
    <nctp:proteinsTG>Extracellular Matrix Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Globulins</nctp:proteinsTG>
    <nctp:proteinsTG>Glycoproteins</nctp:proteinsTG>
    <nctp:proteinsTG>Immunoglobulin Fab Fragments</nctp:proteinsTG>
    <nctp:proteinsTG>Immunoglobulin Fragments</nctp:proteinsTG>
    <nctp:proteinsTG>Immunoglobulin Variable Region</nctp:proteinsTG>
    <nctp:proteinsTG>Immunoglobulins</nctp:proteinsTG>
    <nctp:proteinsTG>Immunoproteins</nctp:proteinsTG>
    <nctp:proteinsTG>Membrane Glycoproteins</nctp:proteinsTG>
    <nctp:proteinsTG>Membrane Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Peptide Fragments</nctp:proteinsTG>
    <nctp:proteinsTG>Peptides</nctp:proteinsTG>
    <nctp:proteinsTG>Proteins</nctp:proteinsTG>
    <nctp:proteinsTG>Scleroproteins</nctp:proteinsTG>
    <nctp:proteinsTG>Serum Globulins</nctp:proteinsTG>
    <nctp:proteinsSH>Activated-Leukocyte Cell Adhesion Molecule [Analysis]</nctp:proteinsSH>
    <nctp:proteinsSH>Activated-Leukocyte Cell Adhesion Molecule [Metabolism]</nctp:proteinsSH>
    <nctp:proteinsSH>Single-Chain Antibodies [Chemistry]</nctp:proteinsSH>
    <nctp:proteinsSH>Single-Chain Antibodies [Genetics]</nctp:proteinsSH>
    <nctp:proteinsSH>Single-Chain Antibodies [Metabolism]</nctp:proteinsSH>
    <nctp:proteinsTS>Activated-Leukocyte Cell Adhesion Molecule</nctp:proteinsTS>
    <nctp:proteinsTS>Single-Chain Antibodies</nctp:proteinsTS>
    <nctp:proteins>Activated-Leukocyte Cell Adhesion Molecule</nctp:proteins>
    <nctp:proteins>Single-Chain Antibodies</nctp:proteins>
    <nctp:neoplasmsTG>Digestive System Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Digestive System Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Disease Models, Animal</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Endocrine Gland Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Endocrine System Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Investigative Techniques</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Models, Animal</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Neoplasms by Site</nctp:neoplasmsTG>
    <nctp:neoplasmsTG>Pancreatic Diseases</nctp:neoplasmsTG>
    <nctp:neoplasmsSH>Neoplasms, Experimental [Chemistry]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Neoplasms, Experimental [Metabolism]</nctp:neoplasmsSH>
    <nctp:neoplasmsSH>Pancreatic Neoplasms [Metabolism]</nctp:neoplasmsSH>
    <nctp:neoplasmsMeSH>Neoplasms, Experimental</nctp:neoplasmsMeSH>
    <nctp:neoplasmsMeSH>Pancreatic Neoplasms</nctp:neoplasmsMeSH>
    <nctp:organisms>Animal</nctp:organisms>
    <nctp:organisms>Mice</nctp:organisms>
    <nctp:organisms>Rat</nctp:organisms>
    <nctp:medicalSpeciality>Oncology</nctp:medicalSpeciality>
    <nctp:neoplasms>Digestive System Neoplasms</nctp:neoplasms>
    <nctp:neoplasms>Endocrine Gland Neoplasms</nctp:neoplasms>
    <nctp:neoplasms>Neoplasms, Experimental</nctp:neoplasms>
    <nctp:imagingTechniques>PET</nctp:imagingTechniques>
    <nctp:element>Copper Radioisotopes</nctp:element>
    <nctp:isotope>Copper 64</nctp:isotope>
    <madec:CASNumber>madec:CASNumber 52-90-4 Cysteine</madec:CASNumber>
    <bibo:pmid>21630083</bibo:pmid>
    <projectfunding:grant>research support, n.i.h., extramural</projectfunding:grant>
    <projectfunding:grant>research support, non-u.s. gov't</projectfunding:grant>
    <dcterms:type>journal article</dcterms:type>
    <nctp:freeAccess>21630083@@Full Text available</nctp:freeAccess>
    <dcterms:source>Mol Imaging Biol. 2012 Jun;14(3):336-47.</dcterms:source>
    <dcterms:language>eng</dcterms:language>
    <madec:medlineSubHeading>Analysis</madec:medlineSubHeading>
    <madec:medlineSubHeading>Chemistry</madec:medlineSubHeading>
    <madec:medlineSubHeading>Genetics</madec:medlineSubHeading>
    <madec:medlineSubHeading>Metabolism</madec:medlineSubHeading>
    <madec:medlineSubHeading>Methods</madec:medlineSubHeading>
    <dcterms:creator>McCabe KE</dcterms:creator>
    <dcterms:creator>Liu B</dcterms:creator>
    <dcterms:creator>Marks JD</dcterms:creator>
    <dcterms:creator>Tomlinson JS</dcterms:creator>
    <dcterms:creator>Wu H</dcterms:creator>
    <dcterms:creator>Wu AM</dcterms:creator>
    <dcterms:issued>20120508</dcterms:issued>
    <madec:medlineIndexationDate>2012-10-30</madec:medlineIndexationDate>
    <madec:pubmedEntryDate>2011-06-2</madec:pubmedEntryDate>
    <dcterms:created>2011-06-2</dcterms:created>
    <madec:publicationYear>2012</madec:publicationYear>
    <bibo:Journal>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</bibo:Journal>
    <dcterms:title>An engineered cysteine-modified diabody for imaging activated leukocyte cell adhesion molecule (ALCAM)-positive tumors.</dcterms:title>
    <dcterms:abstract>PURPOSE : The purpose of this study was to generate and evaluate a positron emission tomography (PET) radiotracer targeting activated leukocyte cell adhesion molecule (ALCAM).PROCEDURES : A human anti-ALCAM single chain variable fragment was reformatted to produce a covalent dimer, termed a cys-diabody (CysDb). Purified CysDb was characterized by gel electrophoresis and size exclusion chromatography, and immunoreactivity was assessed by flow cytometry and immunofluorescence. Targeting and imaging of ALCAM-positive tumors using (64)Cu-DOTA-CysDb were evaluated in mice bearing human pancreatic adenocarcinoma xenografts (HPAF-II or BxPC-3).RESULTS : CysDb binds specifically to ALCAM-positive cells in vitro with an apparent affinity in the range of 1-3 nM. MicroPET images at 4 h showed specific targeting of positive tumors in vivo, a finding confirmed by biodistribution analysis, with positive/negative tumor ratios of 1.9&#8201;&#177;&#8201;0.6 and 2.4&#8201;&#177;&#8201;0.6, and positive tumor/blood ratios of 2.5&#8201;&#177;&#8201;0.9 and 2.9&#8201;&#177;&#8201;0.6 (HPAF-II and BxPC-3, respectively).CONCLUSIONS : Successful imaging with (64)Cu-DOTA-CysDb in animal models suggests further investigation of ALCAM as an imaging biomarker is warranted.</dcterms:abstract>
    <madec:affiliation rdf:resource="aff-069699-1" />
    <madec:publicationCountry>United States</madec:publicationCountry>
    <bibo:issn>1536-1632</bibo:issn>
  </rdf:Description>
  <rdf:Description rdf:about="aff-069699-1">
    <rdf:type rdf:resource="http://castor.example.fr/-/schema/description/type#Affiliation" />
    <madec:totalAffiliation>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA. kmccabe@ucla.edu</madec:totalAffiliation>
    <ad:countryName>USA</ad:countryName>
  </rdf:Description>
</rdf:RDF>
